DICE Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: DICE Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2023.
DICE Therapeutics, Inc. Assets for the quarter ending June 30, 2023 was $551M, a 82% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$551M	+$248M	+82%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$576M	+$251M	+77.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$594M	+$268M	+82.3%	Dec 31, 2022	10-Q	2023-08-08
Q3 2022	$285M	-$57.4M	-16.8%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$303M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$325M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$326M	+$262M	+410%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$342M			Sep 30, 2021	10-Q	2021-11-12
Q4 2020	$63.9M			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.